Investment
Features
FeesSafety
Academy
More
Pluang+

Kevin Warsh's Fed Chair nomination faces Senate hurdles amid policy and investigation concerns.

Market News
15 Apr 2026
Seeking Alpha
View Source
Neutral
pluang ai news

Kevin Warsh's nomination to become the next Federal Reserve Chair faces significant challenges in the Senate, with procedural and political obstacles threatening timely confirmation before current Chair Jay Powell's term ends on May 15. Warsh advocates for a substantial reduction of the Federal Reserve's balance sheet, favoring further Quantitative Tightening beyond recent measures, and is skeptical of prolonged Quantitative Easing due to concerns about unrealized losses and asset bubbles. His preference for fiscal stimulus over monetary stimulus marks a potential shift in policy approach. However, ongoing Department of Justice investigations and Senate opposition create uncertainty around the leadership transition and future Fed policies.

More News

Health plan cuts machine-readable file production from 45 days to under 24 hours with TALON integration

Health plan cuts machine-readable file production from 45 days to under 24 hours with TALON integration

A regional nonprofit health plan reduced its Transparency in Coverage machine-readable file (MRF) production time from 45 days to less than 24 hours by integrating TALON's platform directly with its claims administration system. This eliminated a com...

Others
Neutral
1 hour ago
ASUS launches new durable Chromebooks CM15 and CM32 with long battery life and Google AI features in the US

ASUS launches new durable Chromebooks CM15 and CM32 with long battery life and Google AI features in the US

ASUS has introduced two new Chromebooks in the US market: the budget-friendly CM15 laptop and the versatile CM32 Detachable 2-in-1 device. Both run on the MediaTek Kompanio 540 processor, offer up to 12 hours of battery life, and feature military-gra...

Others
Bullish
2 hours ago
Slate Medicines appoints Mark W. Hahn to board to boost migraine drug development.

Slate Medicines appoints Mark W. Hahn to board to boost migraine drug development.

Slate Medicines, a biotech firm focused on migraine treatments, has appointed Mark W. Hahn to its Board of Directors. Hahn brings over 25 years of experience in life sciences, including leading companies through financial milestones and FDA approvals...

Company Fundamentals
Bullish
3 hours ago
Goldman Sachs posts strong Q2 FY2026 with 38% earnings growth and $31B raised in private credit.

Goldman Sachs posts strong Q2 FY2026 with 38% earnings growth and $31B raised in private credit.

Goldman Sachs reported robust Q2 FY2026 results, with net earnings growing at an annualized rate of 38%. The firm raised $31 billion in private credit and saw a 130% year-over-year surge in equity underwriting revenues, driven by major deals and IPO ...

Company Fundamentals
Bullish
4 hours ago
Bitwise Bitcoin ETF offers low fees but struggles with market share and advisor adoption.

Bitwise Bitcoin ETF offers low fees but struggles with market share and advisor adoption.

The Bitwise Bitcoin ETF (BITB) features competitive fees and tight trading spreads comparable to industry leaders like IBIT and FBTC. Despite strong execution on cost and trading efficiency, BITB's market share and asset growth have stalled due to li...

Analyst Insights
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App